CA2151945C - Epreuve et traitement pour maladies demyelinisantes, comme la sclerose en plaques - Google Patents

Epreuve et traitement pour maladies demyelinisantes, comme la sclerose en plaques Download PDF

Info

Publication number
CA2151945C
CA2151945C CA002151945A CA2151945A CA2151945C CA 2151945 C CA2151945 C CA 2151945C CA 002151945 A CA002151945 A CA 002151945A CA 2151945 A CA2151945 A CA 2151945A CA 2151945 C CA2151945 C CA 2151945C
Authority
CA
Canada
Prior art keywords
multiple sclerosis
antibody
antigen
sample
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002151945A
Other languages
English (en)
Other versions
CA2151945A1 (fr
Inventor
Ellis L. Kline
Daniel H. Zimmerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Signal Coordinating Therapy Inc
Cell Med Inc
Original Assignee
Signal Coordinating Therapy Inc
Cell Med Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Signal Coordinating Therapy Inc, Cell Med Inc filed Critical Signal Coordinating Therapy Inc
Priority claimed from PCT/US1993/012296 external-priority patent/WO1994014846A1/fr
Publication of CA2151945A1 publication Critical patent/CA2151945A1/fr
Application granted granted Critical
Publication of CA2151945C publication Critical patent/CA2151945C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002151945A 1992-12-18 1993-12-17 Epreuve et traitement pour maladies demyelinisantes, comme la sclerose en plaques Expired - Fee Related CA2151945C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US99264192A 1992-12-18 1992-12-18
US992,641 1992-12-18
US16617193A 1993-12-16 1993-12-16
US166,171 1993-12-16
PCT/US1993/012296 WO1994014846A1 (fr) 1992-12-18 1993-12-17 Titrage et traitement destines aux maladies demyelinisantes telles que la sclerose en plaques

Publications (2)

Publication Number Publication Date
CA2151945A1 CA2151945A1 (fr) 1994-07-07
CA2151945C true CA2151945C (fr) 2006-12-05

Family

ID=37558706

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002151945A Expired - Fee Related CA2151945C (fr) 1992-12-18 1993-12-17 Epreuve et traitement pour maladies demyelinisantes, comme la sclerose en plaques

Country Status (1)

Country Link
CA (1) CA2151945C (fr)

Also Published As

Publication number Publication date
CA2151945A1 (fr) 1994-07-07

Similar Documents

Publication Publication Date Title
AU689091B2 (en) Assay and treatment for demyelinating diseases such as multiple sclerosis
Holmdahl et al. Characterization of the antibody response in mice with type II collagen–induced arthritis, using monoclonal anti–type II collagen antibodies
US4935343A (en) Monoclonal antibodies for interleukin-1β
JPS59180362A (ja) 免疫定量法における抗イデイオタイプ抗体の使用
KR0181948B1 (ko) 인체 IgE에 대한 모노클론 항체
EP0386166B1 (fr) ANTICORPS IgM REAGISSANT A LA PROTAMINE
AU703571B2 (en) Isolated 55 to 75 KDA protein which binds to prion protein
EP0345750A2 (fr) Protéase polyfonctionelle
CA2151945C (fr) Epreuve et traitement pour maladies demyelinisantes, comme la sclerose en plaques
JP4071330B2 (ja) 抗ヒトメダラシンモノクローナル抗体、その製造方法及びそれを用いる免疫学的測定方法
EP0465652B1 (fr) Anticorps contre une chaine lourde de myosine des muscles lisses
CA1338841C (fr) Anticorps monoclonaux specifiques pour la fibrinopeptide a humaine
Banga et al. Analysis of antigenic determinants of retinal S-antigen with monoclonal antibodies.
EP0145373A2 (fr) Purification d'une protéine associée au cancer et préparation d'anticorps contre cette protéine
US4743538A (en) Test for rheumatic fever and monoclonal antibodies useful therefor
JP4037933B2 (ja) 抗ヒトカルシトニンモノクローナル抗体
US5516643A (en) Immunochemical assays for cancer-associated SCM-recognition factor
US5747652A (en) Antibody to smooth muscle myosin heavy chains
EP0312645B1 (fr) Peptides antigéniques du facteur C3a du complément, utilisation des peptides, lignées cellulaires, anticorps contre les peptides et utilisation des anticorps
JPH04356198A (ja) モノクローナル抗体及びアシアログリコプロテインレセプターの測定法
Cucina et al. Hybridoma monoclonal antibodies to human fetal haemoglobin
JP3623271B2 (ja) 抗チロシナーゼモノクローナル抗体Ｆａｂフラグメント
JP3522877B2 (ja) 抗チロシナーゼモノクローナル抗体Ｆ（ａｂ’）２フラグメント
EP0423333A1 (fr) Anticorps anti-endoserine
JPH0694707A (ja) 診断方法

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed